Veracyte | VCYT - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agenus USD -221.22M 49.89M 2026-03
Agilent USD 7.12B 214M 2026-03
Anika Therapeutics USD 133.9M 9.56M 2026-03
Arrowhead Research USD 613.98M 45.56M 2026-03
Bruker USD 2.46B 35.9M 2025-12
Heron Therapeutics USD 9.14M 4.15M 2026-03
Illumina USD 2.68B 47M 2026-03
Intrexon USD 43.17M 75.33M 2024-06
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Laboratory Of America USD 8.73B 108.8M 2026-03
Ligand Pharmaceuticals USD 997.32M 19.89M 2026-03
Myriad Genetics USD 337.4M 30.6M 2026-03
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Siemens EUR 64.39B 1.09B 2026-03
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Veracyte USD 1.34B 34.83M 2026-03
Waters USD 2.56B 230.55M 2025-12